Reading: Hakan Samuelsson, CEO of Volvo Cars, said that listing is only an option. At present, Volvo has no concrete plans to look at the decision of its parent Geely. According to the German "Manager" report, Volvo Car CEO Hakan Samuelsson said that the listing is only an option. At present, Volvo has no specific plan. It depends on the decision of the parent company Geely.
Anomatic Corporation, a fully integrated solutions provider for Metal Packaging, continues to expand its capabilities to serve the pharmaceutical and medical device industry producing Metered-dose inhaler (MDI) canisters, insulin pen components and Medical Devices.
Our attention to quality and customer service is at the core of our over 50-year success story allowing us to meet the critical demands of the Pharmaceutical, Medical Device, Military, Aerospace and Cosmetic sectors.
Anomatic has been providing high precision aluminum products since 1965, producing more than 1.1 billion parts annually. Anomatic is well equipped to design and develop customized aerosol cans manufactured to fit your specific pharmaceutical requirements.
Plastic Actuators,Linear Actuator,Electric Actuator,Pneumatic Actuator Anomatic(suzhou)metal packaging co,ltd , https://www.anomaticpharma.com
On December 20, Geely’s Volvo Cars issued a statement announcing that it has successfully obtained a capital of SEK 5 billion (US$ 532 million) from Swedish investors through the latest issuance of preferred stocks, once again taking a step towards the company’s listing. In addition, Volvo also said that the successful financing will dilute Geely shares. In the statement, Volvo said, "This public offering means that Volvo has taken another step towards the long-term dream of listing."
So far, in addition to Geely, there are three shareholders of Volvo: Swedish Pension Fund AMF, Swedish National Pension Reserve Fund (AP1) and Swedish insurance company Folksam.
Volvo: The listing plan will be decided by Geely
Bringing new technology, innovation and cost-effective solutions to the pharmaceutical industry.